FDA
-
-
-
-
-
-
-
Foresee gets positive EU opinion for CAMCEVI 21mg prostate cancer treatment
-
-
-
-
-
-
-
Foresee Pharmaceuticals Announces FDA Approval of CAMCEVI ETM for the Treatment of Advanced Prostate Cancer
-
-
-
-
-
-
-
Foresee Pharmaceuticals Enters Exclusive License Agreement with Intas Pharmaceuticals for Commercialization in the United States
-
-
-
-
-
329,543 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

